-
Product Insights
Guangxi Baise Napo Yangjiashan Wind Farm
Guangxi Baise Napo Yangjiashan Wind Farm is an Onshore Wind project located in Guangxi Zhuang Autonomous Region, China. The project is owned and developed by China Huaneng Group Co Ltd. The project came online in 2023. Empower your strategies with our Guangxi Baise Napo Yangjiashan Wind Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase,...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Crofelemer DR in Cholera
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Crofelemer DR in Cholera report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Crofelemer DR in Cholera Drug Details: Crofelemer (Fulyzaq, Mytesi) is an anti...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Crofelemer DR in Irritable Bowel Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Crofelemer DR in Irritable Bowel Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Crofelemer DR in Irritable Bowel Syndrome Drug Details: Crofelemer (Fulyzaq,...
-
Product Insights
Short Bowel Syndrome – Drugs In Development, 2023
Global Markets Direct’s, ‘Short Bowel Syndrome - Drugs In Development, 2023’, provides an overview of the Short Bowel Syndrome pipeline landscape. The report provides comprehensive information on the therapeutics under development for Short Bowel Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Diarrhea – Drugs In Development, 2023
Global Markets Direct’s, ‘Diarrhea - Drugs In Development, 2023’, provides an overview of the Diarrhea pipeline landscape. The report provides comprehensive information on the therapeutics under development for Diarrhea, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Infectious Diarrhea – Drugs In Development, 2023
Global Markets Direct’s, ‘Infectious Diarrhea - Drugs In Development, 2023’, provides an overview of the Infectious Diarrhea pipeline landscape. The report provides comprehensive information on the therapeutics under development for Infectious Diarrhea, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Chemotherapy-Induced Diarrhea (CID) – Drugs In Development, 2023
Global Markets Direct’s, ‘Chemotherapy-Induced Diarrhea (CID) - Drugs In Development, 2023’, provides an overview of the Chemotherapy-Induced Diarrhea (CID) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chemotherapy-Induced Diarrhea (CID), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Cholera – Drugs In Development, 2023
Global Markets Direct’s, ‘Cholera - Drugs In Development, 2023’, provides an overview of the Cholera pipeline landscape. The report provides comprehensive information on the therapeutics under development for Cholera, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Traveler’s Diarrhea – Drugs In Development, 2023
Global Markets Direct’s, ‘Traveler's Diarrhea - Drugs In Development, 2023’, provides an overview of the Traveler's Diarrhea pipeline landscape. The report provides comprehensive information on the therapeutics under development for Traveler's Diarrhea, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Irritable Bowel Syndrome – Drugs In Development, 2023
Global Markets Direct’s, ‘Irritable Bowel Syndrome - Drugs In Development, 2023’, provides an overview of the Irritable Bowel Syndrome pipeline landscape. The report provides comprehensive information on the therapeutics under development for Irritable Bowel Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...